Page last updated: 2024-11-02

pioglitazone and Complication, Postoperative

pioglitazone has been researched along with Complication, Postoperative in 3 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research Excerpts

ExcerptRelevanceReference
"To examine the impact of a recent surgery on development of endometriosis-related adhesions in a chimeric model and to determine the therapeutic efficacy of pioglitazone (PIO)."3.77Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis. ( Bruner-Tran, KL; Camargos, AF; Carvalho-Macedo, AC; Crispens, MA; Herington, JL; Lebovic, DI; Osteen, KG, 2011)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Lo, C1
Toyama, T1
Oshima, M1
Jun, M1
Chin, KL1
Hawley, CM1
Zoungas, S1
Zhang, Z1
Yuan, H1
Zhao, H1
Qi, B1
Li, F1
An, L1
Herington, JL1
Crispens, MA1
Carvalho-Macedo, AC1
Camargos, AF1
Lebovic, DI1
Bruner-Tran, KL1
Osteen, KG1

Clinical Trials (12)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Efficacy and Safety of Empagliflozin Compared With Linagliptin in New-onset Diabetes Mellitus After Kidney Transplantation[NCT03642184]Phase 46 participants (Actual)Interventional2018-07-14Terminated (stopped due to Difficult in enrolling suitable participants)
Influence of Pioglitazone for Renal Transplant Function in Diabetics - a Double Blind Randomised Placebo Controlled Cross Over Study[NCT00507494]Phase 30 participants Interventional2007-07-31Completed
Treat-To-Target Trial of Continuous Subcutaneous, Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation (SAPT-NODAT)[NCT01680185]Phase 385 participants (Actual)Interventional2012-08-31Completed
A Randomized Controlled Trial of Pioglitazone on Insulin Resistance, Insulin Secretion and Atherosclerosis in Renal Allograft Recipients Without History of Diabetes[NCT00598013]83 participants (Actual)Interventional2004-11-30Completed
Vildagliptin in New Onset Diabetes After Transplantation - A Double-blind, Randomized, Placebo-controlled Trial[NCT00980356]Phase 232 participants (Actual)Interventional2009-09-30Completed
Intravenous Insulin Protocol in Diabetes and Renal Transplantation Study[NCT00609986]104 participants (Actual)Interventional2007-07-31Completed
The Effect of Sitagliptin Treatment on Glucose Metabolism and Endothelial Function in Renal Transplant Recipients - JANUVIA-08[NCT00740363]Phase 425 participants (Actual)Interventional2008-09-30Completed
Treat-to-target Trial of Basal Insulin in Post-transplant Hyperglycemia (TIP): Efficacy and Safety of a Novel Protocol in Renal Transplant Recipients Receiving a Tacrolimus-based Immunosuppression[NCT00830297]Phase 250 participants (Actual)Interventional2009-01-31Completed
Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Post-transplantation Diabetes Mellitus[NCT03157414]Phase 449 participants (Actual)Interventional2016-11-07Completed
Randomized Controlled Trial Comparing the Metabolic Efficiency of Allogeneic Pancreatic Islet Transplantation to Intensive Insulin Therapy for the Treatment of Type 1 Diabetes[NCT01148680]Phase 350 participants (Actual)Interventional2010-06-30Completed
Glucose Control in Pre-Diabetic Renal Transplant Patients: Efficacy and Safety of Vildagliptin and Pioglitazone[NCT01346254]Phase 251 participants (Actual)Interventional2009-12-31Completed
Randomized Study of the Impact of Peri-operative Glucose Control on Short Term Renal Allograft Function After Transplantation[NCT01643382]60 participants (Actual)Interventional2012-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Acute/Active Rejection

Grades IA through III and antibody immediate rejection, either A (immediate or hyperacute) or B (delayed or accelerated acute) were diagnosed and classified based on renal allograft biopsies according to the Banff 97 Working Classification of Renal Allograph Pathology. (NCT00609986)
Timeframe: 30 months

Interventionparticipants (Number)
Intensive9
Control2

Delayed Graft Function

Need for dialysis in the first week post-transplant in a patient who required dialysis pre-transplantation or day-10 post-transplant creatinine concentration above 2.5 mg/dl. (NCT00609986)
Timeframe: 10 days

Interventionparticipants (Number)
Intensive8
Control12

Severe Hyperglycemia

Blood glucose greater than 350 mg/dl. (NCT00609986)
Timeframe: 30 months

Interventionparticipants (Number)
Intensive5
Control12

Severe Hypoglycemia

Blood glucose less than 40 mg/dl (NCT00609986)
Timeframe: 30 months

Interventionparticipants (Number)
Intensive7
Control2

Incidence of Poor Graft Function After Kidney Transplant

Our primary endpoint will be poor initial graft function defined by the occurrence of DGF (defined by a decrease in serum creatinine of <10%/day for 3 consecutive days after transplant) or slow graft function (serum creatinine >3 mg/dL 5 days after transplant without dialysis) (NCT01643382)
Timeframe: 7 days after transplant

InterventionParticipants (Count of Participants)
Tight Glucose Control13
Standard Glucose Control22

Reviews

1 review available for pioglitazone and Complication, Postoperative

ArticleYear
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8

    Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P

2020

Other Studies

2 other studies available for pioglitazone and Complication, Postoperative

ArticleYear
PPARĪ³ activation ameliorates postoperative cognitive decline probably through suppressing hippocampal neuroinflammation in aged mice.
    International immunopharmacology, 2017, Volume: 43

    Topics: Aging; Anilides; Animals; Brain-Derived Neurotrophic Factor; Cells, Cultured; Cognitive Dysfunction;

2017
Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis.
    Fertility and sterility, 2011, Mar-15, Volume: 95, Issue:4

    Topics: Animals; Disease Models, Animal; Endometriosis; Endometrium; Female; Humans; Mice; Mice, Nude; Piogl

2011